Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
324
Views
0
CrossRef citations to date
0
Altmetric
Case Report

First-Line Anlotinib Combined with Stereotactic Body Radiation Therapy for an Octogenarian with Pulmonary Carcinosarcoma

Long Liang1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of China
,
Taiyu Chen2 Clinical Medical College of Chengdu Medical College, Chengdu, 610500, People’s Republic of China
,
Tao Ren3 Oncology Department, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, People’s Republic of China
,
Mian Mao4 Department of Pharmacy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China
,
Keli Wang5 Clinical Medical College of Southwest Medical University, Luzhou, 646000, People’s Republic of China
,
Chunhan Tang2 Clinical Medical College of Chengdu Medical College, Chengdu, 610500, People’s Republic of China
,
Juan Xiao1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of China
,
Hongyuan Jia1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of China
,
Wenli Chen1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of China
,
Qifeng Wang1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-8544-9007
ORCID Icon &
Tao Li1 Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 103-106 | Published online: 06 Jan 2022

References

  • Baldovini C, Rossi G, Ciarrocchi A. Approaches to tumor classification in pulmonary sarcomatoid carcinoma. Lung Cancer. 2019;10:131–149. doi:10.2147/LCTT.S186779
  • Crane CH. Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer. J Radiat Res. 2016;57:i53–i57. doi:10.1093/jrr/rrw016
  • Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.0000000000000630
  • Ersek JL, Symanowski JT, Han Y, et al. Pulmonary carcinosarcoma: a surveillance, epidemiology, and end results (SEER) analysis. Clin Lung Cancer. 2020;21(2):160–170. doi:10.1016/j.cllc.2019.07.001
  • Tanimoto A, Takeuchi S, Kotani H, et al. Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report. BMC Pulm Med. 2018;18(1):193. doi:10.1186/s12890-018-0757-7
  • Tang H, Wu Y. PUB008 successful treatment with apatinib plus human endostatin for refractory recurrent advanced pulmonary carcinosarcoma: a case report. J Thorac Oncol. 2017;12(11):S2367. doi:10.1016/j.jtho.2017.09.1871
  • Han B, Li K, Wang Q, et al. Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial. JAMA Oncol. 2018;4(11):1569–1575. doi:10.1001/jamaoncol.2018.3039
  • Newman NB, Sherry AD, Byrne DW, et al. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer. J Radiat Oncol. 2019;8(2):239–248. doi:10.1007/s13566-019-00395-x
  • Kreinbrink P, Blumenfeld P, Tolekidis G, et al. Lung stereotactic body radiation therapy (SBRT) for early-stage nonsmall cell lung cancer in the very elderly (≥80 years old): extremely safe and effective. J Geriatr Oncol. 2017;8(5):351–355. doi:10.1016/j.jgo.2017.07.002
  • Cuccia F, Mazzola R, Pastorello E, et al. SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity. Clin Exp Metastasis. 2021;38(5):475–481. doi:10.1007/s10585-021-10122-x
  • Parsai S, Lawrenz J, Kilpatrick S, et al. Early outcomes of preoperative 5-fraction radiation therapy for soft tissue sarcoma followed by immediate surgical resection. Adv Radiat Oncol. 2020;5:1274–1279. doi:10.1016/j.adro.2020.06.024
  • Allen M, Silvino D, Kamrava M, et al. Hypofractionated radiation therapy and wound healing after massive sarcoma resection: case report and review of the literature. Int J Surg Case Rep. 2021;83:106005. doi:10.1016/j.ijscr.2021.106005
  • Mizumatsu S, Ryu H, Nomura K, et al. Treating low-grade myxofibrosarcoma with stereotactic body radiation therapy using CyberKnife. Cureus. 2021;13(7):e16393. doi:10.7759/cureus.16393
  • Huang W-L, Huang Y-L, Kao C-N, et al. Stereotactic body radiation therapy for an octogenarian with pulmonary carcinosarcoma. Thorac Cancer. 2021;12(9):1445–1448. doi:10.1111/1759-7714.13922
  • Gao Y, Liu P, Shi R. Anlotinib as a molecular targeted therapy for tumors. Oncol Lett. 2020;20(2):1001–1014. doi:10.3892/ol.2020.11685

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.